Lenalidomide-induced acute interstitial nephritis.

The first case of biopsy-proven lenalidomide-induced acute interstitial nephritis is presented.

[1]  W. Clark,et al.  Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases. , 1980, Annals of internal medicine.

[2]  J. Rossert.  Drug-induced acute interstitial nephritis. , 2001, Kidney international.

[3]  ["Occult" renal insufficiency due to evaluating renal function using only serum creatinine]. , 2002, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[4]  J. Beitz,et al.  Renal failure with the use of zoledronic acid. , 2003, The New England journal of medicine.

[5]  P. Fine,et al.  Toxic acute tubular necrosis following treatment with zoledronate (Zometa). , 2003, Kidney international.

[6]  P. Conte,et al.  Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years. , 2005, The oncologist.

[7]  A. Raza,et al.  Immunomodulatory drugs in myelodysplastic syndromes , 2006, Expert opinion on investigational drugs.

[8]  S. Jagannath,et al.  cells by lenalidomide: therapeutic implications Enhancement of ligand-dependent activation of human natural killer T , 2010 .

[9]  Y. Hegerfeldt,et al.  Azotemia associated with use of lenalidomide in plasma cell dyscrasias , 2008, Leukemia & lymphoma.

[10]  A. Dalgleish,et al.  The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells , 2009, Cancer Immunology, Immunotherapy.

[11]  A. Verma,et al.  Mechanism of action of lenalidomide in hematological malignancies , 2009, Journal of hematology & oncology.